Related references
Note: Only part of the references are listed.Medulloblastoma: Clinical presentation
M. Vinchon et al.
NEUROCHIRURGIE (2021)
CAR-NK Cells in the Treatment of Solid Tumors
Ewa Wrona et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Immune cell landscape and immunotherapy of medulloblastoma
Jin Zhang et al.
PEDIATRIC INVESTIGATION (2021)
CD40 Agonist Antibodies in Cancer Immunotherapy
Robert H. Vonderheide
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells
Yoshinari Ozawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The molecular biology of medulloblastoma metastasis
Randy Van Ommeren et al.
BRAIN PATHOLOGY (2020)
Comparison of DND and mRNA vaccines against cancer
Zohreh Jahanafrooz et al.
DRUG DISCOVERY TODAY (2020)
Medulloblastoma cancer stem cells: molecular signatures and therapeutic targets
Hisham F. Bahmad et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells
Leilei Zhang et al.
CELL DEATH & DISEASE (2020)
MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3)
Ranjana K. Kanchan et al.
BRAIN PATHOLOGY (2020)
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Raju K. Vaddepally et al.
CANCERS (2020)
被撤回的出版物: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma (Retracted article. See vol. 25, pg. 127, 2022)
Alexandra Garancher et al.
NATURE NEUROSCIENCE (2020)
Oncolytic viruses for cancer immunotherapy
Otto Hemminki et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role
Ian J. Purvis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A review of cancer immunotherapy: from the past, to the present, to the future
K. Esfahani et al.
CURRENT ONCOLOGY (2020)
Immunotherapy for Medulloblastoma: Current Perspectives
Tanvir F. Kabir et al.
IMMUNOTARGETS AND THERAPY (2020)
Brain immunology and immunotherapy in brain tumours
John H. Sampson et al.
NATURE REVIEWS CANCER (2020)
MYC Drives Group 3 Medulloblastoma through Transformation of Sox2+ Astrocyte Progenitor Cells
Ran Tao et al.
CANCER RESEARCH (2019)
Medulloblastoma
Paul A. Northcott et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
Christopher T. Petersen et al.
FRONTIERS IN ONCOLOGY (2019)
Towards Immunotherapy for Pediatric Brain Tumors
Stacie Shiqi Wang et al.
TRENDS IN IMMUNOLOGY (2019)
Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis
Ian J. Purvis et al.
JOURNAL OF CLINICAL MEDICINE (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
Michael C. Burger et al.
FRONTIERS IN IMMUNOLOGY (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
1 A Systematic Review of miR-29 in Cancer
Jason J. Kwon et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
New emerging targets in cancer immunotherapy: the role of TIM3
Alex Friedlaender et al.
ESMO OPEN (2019)
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Kevin Bielamowicz et al.
NEURO-ONCOLOGY (2018)
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro et al.
NEURO-ONCOLOGY (2018)
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
Jeroen F. Vermeulen et al.
ONCOIMMUNOLOGY (2018)
Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma
Domenico Orlando et al.
CANCER RESEARCH (2018)
High programmed cell death 1 ligand-1 expression: association with CD8+T-cell infiltration and poor prognosis in human medulloblastoma
Daiki Murata et al.
JOURNAL OF NEUROSURGERY (2018)
Differential patterns of metastatic dissemination across medulloblastoma subgroups
Michal Zapotocky et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2018)
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M. Souweidane et al.
LANCET ONCOLOGY (2018)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
PD-L1 expression in medulloblastoma: an evaluation by subgroup
Allison M. Martin et al.
Oncotarget (2018)
Subgroup-specific immune and stromal microenvironment in medulloblastoma
Michael Bockmayr et al.
ONCOIMMUNOLOGY (2018)
Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
Anandani Nellan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Introduction to checkpoint inhibitors and cancer immunotherapy INTRODUCTION
Arlene H. Sharpe
IMMUNOLOGICAL REVIEWS (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Narek Shaverdian et al.
LANCET ONCOLOGY (2017)
The whole-genome landscape of medulloblastoma subtypes
Paul A. Northcott et al.
NATURE (2017)
Disrupted development and integrity of frontal white matter in patients treated for pediatric medulloblastoma
John O. Glass et al.
NEURO-ONCOLOGY (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Challenges and Recent Advances in Medulloblastoma Therapy
Vinod Kumar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma
Gaylor Boulay et al.
CANCER DISCOVERY (2017)
Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases
Federica Ciregia et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Zijun Y. Xu-Monette et al.
FRONTIERS IN IMMUNOLOGY (2017)
Targeting Malignant Brain Tumors with Antibodies
Rok Razpotnik et al.
FRONTIERS IN IMMUNOLOGY (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology
William M. Pardridge
BIODRUGS (2017)
Immunotherapy for Pediatric Brain Tumors
Elias J. Sayour et al.
BRAIN SCIENCES (2017)
Assessment of Programmed Death-Ligand 1 Expression and Tumor-Associated Immune Cells in Pediatric Cancer Tissues
Robbie G. Majzner et al.
CANCER (2017)
Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40
David J. Messenheimer et al.
CLINICAL CANCER RESEARCH (2017)
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M. G. Cavalli et al.
CANCER CELL (2017)
Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
Christina D. Pham et al.
CLINICAL CANCER RESEARCH (2016)
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Vijay Ramaswamy et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions
Masaki Ueno et al.
BRAIN TUMOR PATHOLOGY (2016)
Timing and Type of Immune Checkpoint Therapy Affect the Early Radiographic Response of Melanoma Brain Metastases to Stereotactic Radiosurgery
Jack M. Qian et al.
CANCER (2016)
Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
Timothy N. Phoenix et al.
CANCER CELL (2016)
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
Leonid Cherkassky et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Active medulloblastoma enhancers reveal subgroup-specific cellular origins
Charles Y. Lin et al.
NATURE (2016)
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Pei-Ling Chen et al.
CANCER DISCOVERY (2016)
IDO1 involvement in mTOR pathway: A molecular mechanism of resistance to mTOR targeting in medulloblastoma
Valentina Folgiero et al.
ONCOTARGET (2016)
Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity
Madiha Derouazi et al.
CANCER RESEARCH (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models
Masashi Chonan et al.
NEURO-ONCOLOGY (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy
Jennifer A. Wargo et al.
SEMINARS IN ONCOLOGY (2015)
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Rikke B. Holmgaard et al.
CELL REPORTS (2015)
RNA-Based Vaccines in Cancer Immunotherapy
Megan A. McNamara et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
Yong Wha Moon et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas
Ashley S. Margol et al.
CLINICAL CANCER RESEARCH (2015)
OX40-and CD27-Mediated Costimulation Synergizes with Anti-PD-L1 Blockade by Forcing Exhausted CD8+ T Cells To Exit Quiescence
Sarah L. Buchan et al.
JOURNAL OF IMMUNOLOGY (2015)
Molecular and In Vivo Characterization of Cancer-Propagating Cells Derived from MYCN-Dependent Medulloblastoma
Zai Ahmad et al.
PLOS ONE (2015)
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)
Sarah K. Tasian et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2015)
Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells
Akemi Kosaka et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Tim-3 on Peripheral CD4+ and CD8+ T Cells Is Involved in the Development of Glioma
Song Han et al.
DNA AND CELL BIOLOGY (2014)
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Paul A. Northcott et al.
NATURE (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Gene Expression Analyses of the Spatio-Temporal Relationships of Human Medulloblastoma Subgroups during Early Human Neurogenesis
Cornelia M. Hooper et al.
PLOS ONE (2014)
Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
Ana C. Anderson
CANCER IMMUNOLOGY RESEARCH (2014)
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma
Minghui Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Agonistic CD40 Antibodies and Cancer Therapy
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2013)
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Nataliya Zhukova et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
Rikke B. Holmgaard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents
Marta Cesca et al.
FRONTIERS IN ONCOLOGY (2013)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
被撤回的出版物: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas (Retracted article. See vol. 41, pg. 1198, 2023)
Xinwei Zhang et al.
CANCER CELL (2012)
Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Deryk Loo et al.
CLINICAL CANCER RESEARCH (2012)
Molecular subgroups of medulloblastoma
Paul A. Northcott et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Drug transport across the blood-brain barrier
William M. Pardridge
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson et al.
NATURE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Medulloblastoma Exosome Proteomics Yield Functional Roles for Extracellular Vesicles
Laura M. Epple et al.
PLOS ONE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Gene Signatures Associated with Mouse Postnatal Hindbrain Neural Stem Cells and Medulloblastoma Cancer Stem Cells Identify Novel Molecular Mediators and Predict Human Medulloblastoma Molecular Classification
Daniela Corno et al.
CANCER DISCOVERY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2011)
Glioma-derived T Cell Immunoglobulin- and Mucin Domain-containing Molecule-4 (TIM4) Contributes to Tumor Tolerance
Lunshan Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Ipilimumab
Vernon K. Sondak et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Dendritic Cell-Based Immunotherapy for Prostate Cancer
Hanka Jaehnisch et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
TP53 Mutation Is Frequently Associated With CTNNB1 Mutation or MYCN Amplification and Is Compatible With Long-Term Survival in Medulloblastoma
Elke Pfaff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma
Fang Xie et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Subtypes of medulloblastoma have distinct developmental origins
Paul Gibson et al.
NATURE (2010)
MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
Hong Xu et al.
CANCER RESEARCH (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma
Ulrich Schueller et al.
CANCER CELL (2008)
Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells
Zeng-Jie Yang et al.
CANCER CELL (2008)
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule
A. Gregorio et al.
HISTOPATHOLOGY (2008)
Presentation of childhood CNS tumours: a systematic review 3 and meta-analysis
Sophie Wilne et al.
LANCET ONCOLOGY (2007)
Angiogenesis in brain tumours
Rakesh K. Jain et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Prospect of targeting the CD40 pathway for cancer therapy
Robert H. Vonderheide
CLINICAL CANCER RESEARCH (2007)
Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology, Group
Patricia L. Robertson et al.
JOURNAL OF NEUROSURGERY (2006)
Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
MC Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
SA Rosenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Hedgehog signaling in animal development: paradigms and principles
PW Ingham et al.
GENES & DEVELOPMENT (2001)
Surveillance neuroimaging to detect relapse in childhood brain tumors: A pediatric oncology group study
AY Minn et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
